Trial intelligence / Profile preview

Compound Nanxing Pain Paste for knee osteoarthritis pain

ChiCTR-TRC-10000963Phase 4Completed

Sponsor
Nanjing University of Chinese Medicine
Start
Jun 2010
Modality
Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of Compound Nanxing Pain Paste in knee osteoarthritis (OA) (3 arms), sponsored by Nanjing University of Chinese Medicine. Primary endpoints: VAS score and Vital signs. Started Jun 2010; status: completed.

02

Drugs

Compound Nanxing Pain Paste
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on ChiCTR-TRC-10000963.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-10000963.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call